This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Find out more about cookies/data protection.

Dravet Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape


Category : News 1 year ago

Dravet syndrome is one of several rare debilitating epileptic encephalopathies of childhood associated with pleomorphic seizure activity, cognitive decline, and motor and behavioral abnormalities. Dravet syndrome is also known as severe myoclonic epilepsy in infancy or polymorphic myoclonic epilepsy in infancy. Various types of seizures seen in Dravet syndrome include convulsive, myoclonic, absence, focal, obtundation status, and tonic seizures.